Your browser doesn't support javascript.
loading
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity.
Neef, Stefan; Heijman, Jordi; Otte, Kristian; Dewenter, Matthias; Saadatmand, Ali R; Meyer-Roxlau, Stefanie; Antos, Christopher L; Backs, Johannes; Dobrev, Dobromir; Wagner, Michael; Maier, Lars S; El-Armouche, Ali.
Affiliation
  • Neef S; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
  • Heijman J; Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
  • Otte K; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Dewenter M; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Saadatmand AR; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Meyer-Roxlau S; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Antos CL; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Backs J; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Dobrev D; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Wagner M; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Maier LS; Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
  • El-Armouche A; Department of Pharmacology and Toxicology, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Naunyn Schmiedebergs Arch Pharmacol ; 390(8): 857-862, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28451724

Full text: 1 Database: MEDLINE Main subject: Proteins / Ryanodine Receptor Calcium Release Channel / Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Myocardium Type of study: Prognostic_studies Limits: Animals Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Proteins / Ryanodine Receptor Calcium Release Channel / Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Myocardium Type of study: Prognostic_studies Limits: Animals Language: En Year: 2017 Type: Article